Milestone Pharmaceuticals Inc.
MISTHealthcare|Biotechnology|CA
$0.76
+0.07 (+10.15%)
DCF Value
$0.15
Tangible Book / Share
$0.13
Cash / Share
$1.23
Clinical Trials (14)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06716021 ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 | Atrial Fibrillation | P3 | Recruiting | 750 | RCT, Double-blind | Placebo, Etripamil |
| NCT05763953 The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) | Paroxysmal Supraventricular Tachycardia | P2 | Recruiting | 60 | Open-label | Etripamil NS |
| NCT03635996 Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 | Paroxysmal Supraventricular Tachycardia | P3 | Terminated | 169 | Open-label | Etripamil NS 70 mg |
| NCT03464019 Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT). | Paroxysmal Supraventricular Tachycardia | P3 | Terminated | 1,097 | RCT, Double-blind | Etripamil, Placebo, Etripamil Test Dose |
| NCT04072835 Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 | Paroxysmal Supraventricular Tachycardia | P3 | Completed | 1,116 | Open-label | Etripamil NS |
| NCT04952610 Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia | Paroxysmal Supraventricular Tachycardia | P3 | Completed | 130 | Open-label | Etripamil NS 70 mg |
| NCT05410860 Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia | Tachycardia, Supraventricular, Paroxysmal Supraventricular Tachycardia | P3 | Completed | 500 | RCT, Double-blind | Etripamil NS 70 mg, Placebo |
| NCT02296190 Efficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm | Paroxysmal Supraventricular Tachycardia (PSVT) | P2 | Completed | 199 | RCT, Double-blind | Etripamil, Placebo |
| NCT04467905 ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2 | Atrial Fibrillation | P2 | Completed | 69 | RCT, Double-blind | Etripamil, Placebo |
| NCT05511870 A Study of Etripamil in Healthy Subjects | Healthy Chinese Subjects | P1 | Completed | 12 | RCT, Double-blind | Etripamil Nasal Spray 70mg, Placebo |
| NCT03353610 The PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry. | Paroxysmal Supraventricular Tachycardia (PSVT) | Terminated | 354 | — | — | |
| NCT03920345 Endoscopic Electrothermic Procedure of the Sacroiliac Joint | Chronic Lower Back Pain (CLBP), SIJ Arthropathy | N/A | Terminated | 5 | Open-label | — |
| NCT02378727 CompuFlo® Assessment Study for the Epidural Space Verification | Verification of Needle Tip Placement in the Lumbar Epidural Space | N/A | Unknown | 400 | RCT, Open-label | — |
| NCT02982226 ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis | Fasciitis, Plantar | N/A | Unknown | 150 | RCT, Single-blind | — |